Fuh, K., Moore, K., Baert, T., Herzog, T., Cibula, D., Liu, J., … Gonzalez-Martin, A. (2022). TP023/#1560 A phase 3, randomized, double-blind, placebo/paclitaxel-controlled study of batiraxcept in combination with weekly paclitaxel in patients with platinum-resistant recurrent ovarian cancer (GOG-3059/ENGOT OV-66). In E-Posters (Trials In Progress) (p. A234.2-A235). BMJ Publishing Group Ltd. https://doi.org/10.1136/ijgc-2022-igcs.532

Fuh, Katherine, Kathleen Moore, Thais Baert, Thomas Herzog, David Cibula, Joyce Liu, Laurianne Eberst, et al. “TP023/#1560 A phase 3, randomized, double-blind, placebo/paclitaxel-controlled study of batiraxcept in combination with weekly paclitaxel in patients with platinum-resistant recurrent ovarian cancer (GOG-3059/ENGOT OV-66).” In E-Posters (Trials In Progress), A234.2-A235. BMJ Publishing Group Ltd, 2022. https://doi.org/10.1136/ijgc-2022-igcs.532.

Fuh K, Moore K, Baert T, Herzog T, Cibula D, Liu J, et al. TP023/#1560 A phase 3, randomized, double-blind, placebo/paclitaxel-controlled study of batiraxcept in combination with weekly paclitaxel in patients with platinum-resistant recurrent ovarian cancer (GOG-3059/ENGOT OV-66). In: E-Posters (Trials In Progress). BMJ Publishing Group Ltd; 2022. p. A234.2-A235.

Fuh, Katherine, et al. “TP023/#1560 A phase 3, randomized, double-blind, placebo/paclitaxel-controlled study of batiraxcept in combination with weekly paclitaxel in patients with platinum-resistant recurrent ovarian cancer (GOG-3059/ENGOT OV-66).” E-Posters (Trials In Progress), BMJ Publishing Group Ltd, 2022, p. A234.2-A235. Crossref, doi:10.1136/ijgc-2022-igcs.532.

Fuh K, Moore K, Baert T, Herzog T, Cibula D, Liu J, Eberst L, Lewin S, Secord AA, Sehouli J, Myers T, Bamias A, Rimel BJ, Colombo N, Franke A, Shoop D, Giorgi UD, Pikiel J, Bowen R, Gonzalez-Martin A. TP023/#1560 A phase 3, randomized, double-blind, placebo/paclitaxel-controlled study of batiraxcept in combination with weekly paclitaxel in patients with platinum-resistant recurrent ovarian cancer (GOG-3059/ENGOT OV-66). E-Posters (Trials In Progress). BMJ Publishing Group Ltd; 2022. p. A234.2-A235.